NASDAQ: LSDILucy Scientific Discovery Inc Stock
$1.13+0.00 (+0%)
Updated May 26, 2023
LSDI Price
$1.13
Fair Value Price
N/A
Market Cap
$18.47M
52 Week Low
$0.83
52 Week High
$4.00
P/E
N/A
P/B
3.1x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.58
Operating Cash Flow
N/A
Beta
0.73
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
LSDI Overview
Lucy Scientific Discovery Inc. researches, develops, manufactures, and commercializes psychedelic products. It offers biological raw materials, crude extracts, psychotropic compounds, and active pharmaceutical ingredients (APIs). Lucy Scientific Discovery Inc. was formerly known as Hollyweed North Cannabis, Inc. The company was incorporated in 2017 and is based in Victoria, Canada.
Zen Score
–
Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how LSDI scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
LSDI is good value based on its book value relative to its share price (3.1x), compared to the US Biotechnology industry average (5.18x)
P/B vs Industry Valuation
LSDI's short-term assets ($5.80M) exceed its short-term liabilities ($2.07M)
Short-term Liabilities Financials
LSDI's short-term assets ($5.80M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
There are 30 more LSDI due diligence checks available for Premium users.
Be the first to know about important LSDI news, forecast changes, insider trades & much more!
LSDI News
Valuation
LSDI price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
3.1x
Industry
5.18x
LSDI is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
LSDI's financial health
Profit margin
Revenue
$0.0
Net Income
-$4.1M
Profit Margin
0%
Assets to liabilities
Assets
$9.4M
Liabilities
$3.4M
Debt to equity
0.58
LSDI's short-term assets ($5.80M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
LSDI's short-term assets ($5.80M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
LSDI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$2.0M
Investing
-$300.0k
Financing
$5.9M
LSDI vs Biotech Stocks
Lucy Scientific Discovery Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.